ACC: Prediabetes May Raise Risk for Major Adverse CV Events
THURSDAY, May 13, 2021 -- Prediabetes appears to be a risk factor for increased incidence of major adverse cardiovascular events (MACE), according to a study presented at the annual meeting of the American College of Cardiology, held virtually from May 15 to 17.
Adrian Michel, M.D., from Beaumont Health in Royal Oak, Michigan, and colleagues followed 25,829 patients who had either prediabetes (12,691 individuals) or normal hemoglobin A1c levels (13,138 individuals [control group]) for 14 years to evaluate the role of prediabetes in the development of cardiovascular disease.
The researchers found that the incidence of MACE in the prediabetes group (17.97 percent) was significantly higher than MACE incidence in the control group (11.01 percent). This finding remained significant even after accounting for confounding factors such as age, gender, body mass index, blood pressure, cholesterol, sleep apnea, smoking status, and peripheral artery disease.
"In general, we tend to treat prediabetes as no big deal. But we found that prediabetes itself can significantly boost someone's chance of having a major cardiovascular event, even if they never progress to having diabetes," Michel said in a statement. "Instead of preventing diabetes, we need to shift focus and prevent prediabetes."
© 2021 HealthDay. All rights reserved.
Posted May 2021
Read this next
FRIDAY, June 18, 2021 -- Having diabetes and frequent sleep disturbances increases the risk for early death, according to a study published online June 8 in the Journal of Sleep...
THURSDAY, June 17, 2021 -- Dietary interventions, like the Dietary Approaches to Stop Hypertension (DASH) diet and low sodium consumption, can improve cardiovascular risk factors...
TUESDAY, June 15, 2021 -- Dietary strategies aimed solely at lowering saturated fat intake may be less effective in reducing cardiovascular disease (CVD) than recommendations for...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.